Science Explorer Back to mapMap
Discussion
Researcher · Luminex (United States) · United States

Stephen V. Angeloni

Stephen V. Angeloni publishes mostly in Molecular Biology, Infectious Diseases and Cell Biology, on topics such as Advanced Biosensing Techniques and Applications, SARS-CoV-2 and COVID-19 Research and SARS-CoV-2 detection and testing.

OpenAlex
World rank
#5,452,774
of 7,710,434 ranked researchers
Rank in United States
#1,378,254
of 1,627,098
Works
19
Citations
428
Citations per work
22.5
h-index
10
i10-index 10Top 76% in Molecular Biology
Stephen V. Angeloni

What does Stephen V. Angeloni research?

Stephen V. Angeloni's work is mostly in Medicine (29%), Biochemistry, Genetics and Molecular Biology (27%), Neuroscience (6%).

Everything else: 7 works · 38.0% of their workLife Sciences: 6 works · 32.8% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 27.3% of their workMolecular Biology: 4 works · 20.0% of their workCell Biology: 1 works · 7.3% of their workNeuroscience: 1 works · 5.5% of their workEndocrine and Autonomic Systems: 1 works · 5.5% of their workHealth Sciences: 6 works · 29.2% of their workMedicine: 6 works · 29.2% of their workInfectious Diseases: 3 works · 16.4% of their workPhysiology: 1 works · 7.3% of their workEpidemiology: 1 works · 5.5% of their workTHEIR WORKStephen V.Angeloni19works
Life Sciences33%Health Sciences29%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else738.0%
    1. Biochemistry, Genetics and Molecular Biology527.3%
    2. Neuroscience15.5%
    1. Medicine629.2%
  1. 1Molecular Biology20% of their works
  2. 2Infectious Diseases16% of their works
  3. 3Cell Biology7% of their works
  4. 4Physiology7% of their works
  5. 5Endocrine and Autonomic Systems6% of their works
  6. 6Epidemiology6% of their works

Research topics

Which keywords describe Stephen V. Angeloni's research?

The keywords of their largest research topics: SARS-CoV-2, Coronavirus, COVID-19, Diagnostics, High-Throughput Analysis, Metabolic Disorders, Protein Microarrays and Vaccine.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. SARS-CoV-282 topics
  2. COVID-1941 topic
  3. Coronavirus41 topic
  4. Diagnostics41 topic
  5. High-Throughput Analysis41 topic
  6. Metabolic Disorders42 topics
  7. Protein Microarrays41 topic
  8. Vaccine41 topic
  9. Biological Soil Crusts31 topic
  10. Cyanobacteria31 topic
  11. Ghrelin31 topic
  12. Hemoglobin31 topic
  13. Leptin31 topic
  14. Scavenger Receptor31 topic
  15. Amino Acid Transporters21 topic
  16. Biochemical Genetics21 topic
  17. D-Serine21 topic
  18. Newborn Screening21 topic

Where does Stephen V. Angeloni work?

Stephen V. Angeloni's main affiliation in the publication record is Luminex (United States), United States.

How many publications and citations does Stephen V. Angeloni have?

OpenAlex counts 19 works and 428 citations for Stephen V. Angeloni, an h-index of 10, ranking #5,452,774 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stephen V. Angeloni. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.